Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion type Assertion NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_head.
- NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion description "[In pancreatic cancer, 15/31 (48.4%) patients showed overexpression of SPARC (ratio tumor/normal >1) whereas in CPV only 1/8 (12.5%) exhibited SPARC overexpression and this difference was statistically significant (p<0.05, Mann-Whitney test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion evidence source_evidence_literature NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion SIO_000772 16596217 NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion wasDerivedFrom befree-20140225 NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion wasGeneratedBy ECO_0000203 NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.